About Department of Hematology, Vejle Hospital
Clinical Trials at Department of Hematology, Vejle Hospital
During the past decade, Department of Hematology, Vejle Hospital conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on
average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Department of Hematology, Vejle Hospital" #1 sponsor was "Celgene" with 1 trials, followed by "Celgene Corporation" with 1 trials
sponsored, "Henrik Gregersen" with 1 trials sponsored, "Nordic MDS Group" with 1 trials sponsored and "Vejle Hospital"
with 1 trials sponsored. Other sponsors include -5 different institutions and
companies that sponsored additional 5 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Department of Hematology, Vejle Hospital"
#1 collaborator was "Danish Myeloma Study Group" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Department of Hematology, Vejle Hospital
According to Clinical.Site data, the most researched conditions in "Department of Hematology, Vejle Hospital" are
"Multiple Myeloma" (3 trials), "AML" (1 trials), "MDS" (1 trials) and "Myelodysplastic Syndromes" (1 trials). Many other conditions were trialed in "Department of Hematology, Vejle Hospital" in a lesser frequency.
Clinical Trials Intervention Types at Department of Hematology, Vejle Hospital
Most popular intervention types in "Department of Hematology, Vejle Hospital" are "Drug" (5 trials). Other intervention types were less common.
The name of intervention was led by "CC-5013" (1 trials), "Clarithromycin" (1 trials), "Daratumumab" (1 trials), "Dexamethasone" (1 trials) and "Lenalidomide" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Department of Hematology, Vejle Hospital
The vast majority of trials in "Department of Hematology, Vejle Hospital" are
5 trials for "All" genders.
Clinical Trials Status at Department of Hematology, Vejle Hospital
Currently, there are NaN active trials in "Department of Hematology, Vejle Hospital".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 4 completed trials in Department of Hematology, Vejle Hospital,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Department of Hematology, Vejle Hospital, 0 "Phase 1"
clinical trials were conducted, 4 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".